During the past decade, Joan Karnell Cancer Center at Pennsylvania Hospital conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 16 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 4 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Joan Karnell Cancer Center at Pennsylvania Hospital" #1 sponsor was "Eastern Cooperative Oncology Group" with 8 trials, followed by "Alliance for Clinical Trials in Oncology" with 7 trials sponsored, "AIDS Malignancy Consortium" with 4 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 2 trials sponsored and "Gynecologic Oncology Group" with 2 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Joan Karnell Cancer Center at Pennsylvania Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 26 trials as a collaborator, "SWOG Cancer Research Network" with 4 trials as a collaborator, "The Emmes Company, LLC" with 4 trials as a collaborator, "NCIC Clinical Trials Group" with 3 trials as a collaborator and "North Central Cancer Treatment Group" with 3 trials as a collaborator. Other collaborators include 3 different institutions and companies that were collaborators in the rest 11 trials.

According to Clinical.Site data, the most researched conditions in "Joan Karnell Cancer Center at Pennsylvania Hospital" are "Breast Cancer" (5 trials), "Lung Cancer" (4 trials), "Lymphoma" (4 trials), "Anal Cancer" (3 trials) and "Colorectal Cancer" (2 trials). Many other conditions were trialed in "Joan Karnell Cancer Center at Pennsylvania Hospital" in a lesser frequency.

Most popular intervention types in "Joan Karnell Cancer Center at Pennsylvania Hospital" are "Drug" (23 trials), "Biological" (10 trials), "Radiation" (7 trials), "Other" (3 trials) and "Genetic" (1 trials). Other intervention types were less common.

The name of intervention was led by "cisplatin" (5 trials), "cetuximab" (4 trials), "fluorouracil" (4 trials), "radiation therapy" (4 trials) and "cyclophosphamide" (3 trials). Other intervention names were less common.

The vast majority of trials in "Joan Karnell Cancer Center at Pennsylvania Hospital" are 23 trials for "All" genders and 4 trials for "Female" genders.

Currently, there are NaN active trials in "Joan Karnell Cancer Center at Pennsylvania Hospital". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 24 completed trials in Joan Karnell Cancer Center at Pennsylvania Hospital, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Joan Karnell Cancer Center at Pennsylvania Hospital, 0 "Phase 1" clinical trials were conducted, 11 "Phase 2" clinical trials and 13 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".